Type: Ingredient entity — regulatory & claim record
Topic: Adenosine — cosmetic functional ingredient (wrinkle improvement)
Evidence basis: MFDS Functional Cosmetic Ingredient Notification, KCIA ingredient list, PubChem chemical identity
Last Verified: 2026-05-23
This page does not make treatment, disease prevention, or efficacy claims. See the Evidence Boundaries section below for what this page does not assert.
What Is Adenosine in Korean Cosmetics?
Adenosine (아데노신) is a naturally occurring nucleoside compound that is officially recognized as a functional cosmetic ingredient in South Korea. Under the Ministry of Food and Drug Safety (MFDS) notification system for functional cosmetics, adenosine is listed as a permitted wrinkle-improvement ingredient when used at a concentration of 0.04% or above, provided the product has completed the required regulatory reporting process.
In the Korean cosmetic market, adenosine appears primarily in anti-aging formulations — serums, creams, and ampoules positioned around skin texture and appearance. Its regulatory status under the MFDS functional cosmetic framework means that manufacturers who include adenosine at the threshold concentration can make wrinkle-related labeling claims, within the boundaries set by regulation.
A critical context note: adenosine is also the same molecule used as a prescription cardiovascular drug (for arrhythmia management). These are entirely different regulatory and clinical contexts. The cosmetic use of adenosine operates under Korean cosmetics law (화장품법), not pharmaceutical regulation (약사법), and no cardiovascular or systemic pharmacological claims are applicable or permissible in cosmetic labeling. This distinction is explained in the Evidence Boundaries section.
Ingredient Snapshot
| Field | Value |
|---|---|
| Ingredient Name | Adenosine |
| Korean Name | 아데노신 |
| INCI Name | Adenosine |
| Synonyms | 9-β-D-Ribofuranosyladenine; Adenine riboside |
| CAS No. | 58-61-7 |
| Ingredient Type | Functional Ingredient |
| Cosmetic Role | Anti-aging; wrinkle improvement |
| Supplement Function | Not applicable (not a notified supplement ingredient) |
| Status | To Review |
Regulatory Records
Functional Cosmetic Ingredient Notification (고시형)
- Jurisdiction: Republic of Korea
- Issuing Body: Ministry of Food and Drug Safety (MFDS / 식품의약품안전처)
- Record Number: MFDS Functional Cosmetic Ingredient Notification, Annex 2
(원문: 식품의약품안전처 고시 별표 2 — 기능성화장품 고시 원료) - Scope:
- Wrinkle improvement
- Permitted at 0.04% or above
- Reporting-based registration (보고) required before labeling claims
- Status: Active (MFDS-notified)
- Source: MFDS functional cosmetic ingredient list
Pharmaceutical Classification
- Jurisdiction: Republic of Korea
- Issuing Body: MFDS
- Record Number: Unknown
- Scope:
- Prescription cardiovascular drug context
- Entirely separate from cosmetic-use context
- No cosmetic labeling claims permitted under this classification
- Status: Active pharmaceutical classification (separate context)
- Source: Unknown
Claim Safety Matrix
Note: Claim Type classifications in this table are preliminary and subject to human review. AI-assisted classification only. Final Allowed/Prohibited determination requires regulatory verification.
| Claim Text | Claim Type | Why It Matters | Safer Alternative Wording | Source |
|---|---|---|---|---|
| Contains adenosine, a wrinkle-improvement ingredient recognized under the Korean MFDS functional cosmetic notification system | To Review (Allowed candidate) | Adenosine is a listed 고시형 functional ingredient for wrinkle improvement at ≥0.04%. This type of statement describes regulatory status without asserting personal efficacy. | Use as-is, conditional on product having completed MFDS reporting (보고) at the required concentration | MFDS 기능성화장품 고시 원료 목록 |
| Helps reduce the appearance of wrinkles (제품 표시에 사용하는 경우) | To Review (Caution candidate) | 허용 표현 범위이나 반드시 보고 완료 제품에 한함. 보고 없이 기능성 라벨링은 위반. | Only permissible for products that have completed MFDS 기능성화장품 보고. Do not generalize to all adenosine-containing products. | MFDS 기능성화장품 보고 제도 |
| Adenosine repairs skin at the cellular level | Avoid | “Cellular repair” implies physiological/drug-level action not supported by cosmetic regulatory context. Risks crossing into pharmaceutical efficacy language. | Remove. Describe ingredient function within cosmetic framework only. | 화장품법 제2조 (화장품 정의 — 인체에 대한 작용이 경미한 것) |
| Adenosine treats wrinkles / cures aging skin | Prohibited | 치료(treatment) 표현은 화장품에 금지. 의약품 효능 암시로 화장품법 위반. | Do not use. No alternative — remove entirely. | 화장품법 제13조 (표시·광고의 금지 등) |
| Adenosine supports heart health / cardiovascular function | Prohibited | 아데노신의 심장 관련 약리 작용은 전문의약품(처방약) 맥락. 화장품에 이 claim 사용은 허위·과대광고에 해당. 맥락 혼용 절대 금지. | Do not use under any circumstances in cosmetic labeling or marketing. | 약사법 (전문의약품 관련 규정); 화장품법 제13조 |
Evidence Boundaries: What This Page Does Not Claim
The following claims are outside the scope of this ingredient record:
No disease treatment or prevention claims. Adenosine in cosmetic formulations is regulated under Korean cosmetics law (화장품법), which explicitly defines cosmetics as products with mild effects on the body — not treatment or prevention of disease. No claim that adenosine in cosmetics treats, cures, or prevents any medical condition is supported by this record.
No cardiovascular or pharmaceutical efficacy claims. Adenosine is also a prescription drug used in cardiovascular medicine. That pharmacological context is entirely separate from its cosmetic use. This page does not assert any connection between cosmetic adenosine use and cardiovascular function, and such claims would constitute a serious regulatory violation in Korean cosmetic labeling.
No guaranteed personal efficacy. Regulatory recognition as a functional cosmetic ingredient does not mean every individual will experience the same results. This page does not assert that adenosine will produce specific measurable wrinkle reduction for any individual.
No product endorsement. This page records the ingredient’s regulatory status and claim boundaries. It does not recommend any specific product or brand.
Related Entities
Related Ingredients
- Niacinamide — another MFDS-notified functional cosmetic ingredient (brightening)
- Retinol — wrinkle improvement category (고시형), separate regulatory record
- Ascorbic Acid (Vitamin C) — brightening category (고시형), separate regulatory record
Related Product Types
- Anti-aging serums (기능성화장품 보고 완료 제품)
- Wrinkle-improvement creams and ampoules
- Functional cosmetic products with MFDS wrinkle-improvement certification
Related Claims
- Wrinkle improvement — 고시형 기능성화장품 허용 표현 범위
- Functional cosmetic labeling — 보고 완료 조건부 허용
Related Regulatory Concepts
- 기능성화장품 고시형 원료 (MFDS functional cosmetic notified ingredients)
- 기능성화장품 보고 제도 (functional cosmetic reporting system)
- 화장품법 제13조 (labeling and advertising restrictions)
- 약사법 / 전문의약품 구분 (pharmaceutical vs. cosmetic regulatory boundary)
Source Transparency Note
| Source | Role | Authority Scope | Limit |
|---|---|---|---|
| MFDS 기능성화장품 고시 원료 목록 | Regulatory | Allowed claims, regulatory status, concentration thresholds | 화장품 category only |
| KCIA (대한화장품원료집) | Naming | INCI명, 한글명, synonym 확인 | 기능성 claim 근거 불가 |
| PubChem (CAS 58-61-7) | Chemical identity | CAS No., molecular structure, chemical properties | 규제·claim 정보 없음 |
| 화장품법 / 약사법 | Legal framework | Claim prohibition basis, regulatory boundaries | 법령 해석은 전문가 확인 필요 |
KCIA는 naming 및 synonym 확인용으로만 사용한다. KCIA 단독으로 기능성·의료적 claim의 근거로 삼지 않는다.
Frequently Asked Questions
Is adenosine a regulated functional ingredient in Korean cosmetics?
Yes. Adenosine is listed as a 고시형 (notified) functional cosmetic ingredient under the South Korean MFDS regulatory framework for wrinkle improvement. Products must contain adenosine at 0.04% or above and must complete the MFDS 기능성화장품 보고 (reporting) process before using wrinkle-improvement labeling claims.
What claims are allowed for adenosine in Korean cosmetics?
Under the MFDS functional cosmetic notification system, adenosine-containing products that have completed the required reporting process may use wrinkle-improvement related labeling within the scope defined by regulation. Claims must not imply drug-level treatment, disease prevention, or physiological repair. The exact permitted wording is defined by the MFDS 기능성화장품 고시.
Can adenosine cosmetic claims mention disease treatment?
No. Adenosine used in cosmetics is regulated under 화장품법, which prohibits treatment or disease-prevention claims. Any claim that adenosine in a cosmetic product treats, cures, or prevents a medical condition would constitute a violation of Korean cosmetic labeling regulations (화장품법 제13조).
Is adenosine in skincare the same as the heart medication?
Adenosine (CAS 58-61-7) is chemically the same molecule used in certain cardiovascular prescription drugs. However, the regulatory contexts are entirely separate. Cosmetic adenosine is governed by 화장품법 at topical application concentrations and conditions. Cardiovascular adenosine is a prescription drug under 약사법. No cardiovascular or systemic pharmacological claims are permissible in cosmetic contexts, and mixing these contexts in labeling or marketing is a regulatory violation.
What concentration of adenosine is required for functional cosmetic status in Korea?
The MFDS functional cosmetic notification requires adenosine to be present at a concentration of 0.04% or above for wrinkle-improvement claims. Products below this threshold, or products that have not completed the MFDS reporting process, may not use functional cosmetic wrinkle-improvement labeling.